Skip to content
Search the site

Clinical trial NCT06477406

Status: Active, not recruitingPhase 2Latest change: Source: ClinicalTrials.gov

What's on this page?

Information in the record

Original title: Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis

Record number
NCT06477406
Status
Active, not recruiting
Type and phase
Clinical trial, phase 2
Participants
Target: 30
Condition (as registered)
Endometriosis
Countries
United States
Topic in the guide
Outside the topics in the guide

Timeline

According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.

  • Start: February 27, 2024
  • End of data collection for primary results: December 2026 (expected)
  • Trial completion: December 2026 (expected)

History

We check the record every day; here are the changes we have seen since we started tracking it, newest first.

  • : Added to tracking. Status: Active, not recruiting.

Results

No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.

All ongoing trials · Thinking of taking part? Which specialist to see